findmyKOL

Maroun Tawk, MD

Basic profile

University of Oklahoma Health Sciences Center

ORCIDNone on fileNPI
RegionOklahoma City, OK · South CentralSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2009Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Maroun Tawk is a Respiratory physician affiliated with University of Oklahoma Health Sciences Center. OpenAlex indexes 20 publications with 618 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
20publications

Distinct works indexed by OpenAlex.

618citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
48companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

13313 N Meridian Ave
Building D
Oklahoma City, OK 73120

Telephone

405-755-4290

Registry record last updated 24 Jul 2018.

View the NPPES registry record

Industry payments

48 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    69%
    Benzodiazepine related drugs15.2%
    Eszopiclone100%
    Part D43 patients
    Gabapentinoids10.5%
    Gabapentin100%
    Part D35 patients

    + 12 more classes in this area

  • Respiratory

    28.9%
    Corticosteroid17.6%
    Trelegy Ellipta67%Symbicort8%Breo Ellipta7%Breztri Aerosphere7%Fluticasone Propionate6%Arnuity Ellipta5%
    Part D<11 patients
    Leukotriene Receptor Antagonist6%
    Montelukast Sodium100%
    Part D21 patients

    + 3 more classes in this area

  • Metabolism & gastrointestinal

    1.4%
    Corticosteroid1.4%
    Prednisone100%
    Part D<11 patients
Where care is delivered (Part B)66.8% facility · 33.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”